UCI, founded in 1965, is among the most dynamic campuses in the University of California’s ten-campus system with nearly 28,000 students, 1,100 faculty and 9,000 staff. The university is noted for its excellent research and graduate programs, and a growing number of professional schools. Ranked as one of the top 50 US medical schools, UCI’s School of Medicine is dedicated to advancing knowledge and clinical practice through research, physician education and high-quality care. UCI Medical Center recently opened UCI Douglas Hospital, housing the latest technologies and strengthening UCI’s ability to provide specialized treatments. The Office of Technology Alliances (OTA) manages UCI’s intellectual property, helps increase research support from the private sector, and assists faculty with industry-related activities. OTA emphasizes accessibility, timeliness and flexibiity in fostering university/industry interactions.
Featured Startups and Technologies
ALEKS (Assessment and LEarning in Knowledge Spaces), Inc., founded in 1996 by Professor Jean-Claude Falmagne, is the practical realization of extensive research in mathematical cognitive science supported by NSF. ALEKS is a web-based, artificial intelligent system that uses adaptive questioning to determine what a student does or does not know and then instructs the student on the topics she is most ready to learn. ALEKS is used by hundreds of thousands of students annually in over 50 courses ranging from Grade 3 Mathematics to Pre-Calculus at K-12 and higher education institutions throughout the world.
Cortex Pharmaceuticals, Inc.
Cortex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs called AMPAKINE molecules targeted towards the treatment of human central nervous system diseases. Crucial research into these compounds was funded by NIH in the UCI lab of Gary Lynch, Ph.D. AMPAKINE molecules represent a new approach to treating psychiatric disorders, neurological diseases and brain mediated breathing disorders through their ability to increase communication between brain cells.
One-Cycle Control, Inc.
One-Cycle Control, Inc. (OCC) technology was invented at CalTech and further developed at UCI using NSF, DOE and Discovery Grants. OCC’s technology delivers active conversion of 3-phase power without software by requiring no Digital Signal Processor (DSP) nor software in the control loop, leading to reduced design steps, decreased component count, and improved reliability and performance necessary for high-volume manufacturing and large-scale deployment.
SoundCure is focused on developing and commercializing a novel acoustic therapy for the treatment and suppresion of tinnitus (ringing in the ear). UCI Professor Fan Gang Zeng’s research that led to this therapy was funded by NIH and the American Tinnitus Assoc. The company is partnering with audiologists, MDs and patient advocacy groups to leverage innovative web-based technologies to treat patients and provide tinnitus solutions. Allied Minds and UCI have teamed up to establish SoundCure.
Office of Technology Alliances
5171 California Avenue
Irvine, CA 92697-7700
Phone: (949) 824-7295